BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising progress across numerous health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA provides a safer, more dependable alternate for therapeutic use, spe